PharmEasy Founders' All Home Raises ₹200Cr, Doubles Valuation to ₹2,000Cr
The second act from PharmEasy's founding team is off to a fast start. All Home's ₹200 crore funding round and annualised ₹400 crore run rate validate its vision for the building materials sector, while its investor backing highlights continued faith in the team.